ISRG 📈 Intuitive Surgical - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US46120E6023
ISRG: Surgical Systems, Robotic Instruments, Diagnostic Tools, Medical Software
Intuitive Surgical, Inc. is a pioneer in the development, manufacturing, and marketing of cutting-edge medical products, primarily focused on enhancing the quality and accessibility of minimally invasive care globally. The company's flagship product, the da Vinci Surgical System, has revolutionized the field of surgery by enabling complex procedures to be performed using a minimally invasive approach, resulting in reduced scarring, less pain, and faster recovery times for patients. This innovative system has been widely adopted by hospitals and healthcare providers worldwide, and its impact on the medical industry has been significant.
Building on the success of the da Vinci Surgical System, Intuitive Surgical has expanded its product portfolio to include the Ion endoluminal system, which marks a significant extension of the company's commercial offerings into diagnostic procedures. The Ion system enables minimally invasive biopsies in the lung, providing healthcare providers with a more effective and less invasive way to diagnose and treat lung cancer. Additionally, the company offers a range of complementary products, including stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems, as well as progressive learning pathways to support the adoption and effective use of its technology.
Intuitive Surgical's commitment to customer support is evident in its comprehensive suite of services, which includes installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring. The company's infrastructure of service and support specialists ensures that its customers receive timely and effective assistance, minimizing downtime and optimizing system performance. Furthermore, Intuitive Surgical's integrated digital capabilities provide connected offerings that streamline performance for hospitals, offering program-enhancing insights that help healthcare providers optimize their use of the company's products and improve patient outcomes.
The company's sales strategy is centered on direct sales organizations, including capital and clinical sales teams, which work closely with healthcare providers to understand their needs and provide tailored solutions. Intuitive Surgical has also established strategic collaborations, such as its agreement with FluoGuide A/S for head and neck cancer, to further expand its product offerings and improve patient care. With a strong foundation in the medical industry, Intuitive Surgical continues to innovate and push the boundaries of what is possible in minimally invasive care, with a focus on delivering high-quality products and services that enhance patient outcomes and improve the overall quality of healthcare.
As a publicly traded company, Intuitive Surgical is committed to transparency and accountability, with a strong governance structure in place to ensure the long-term sustainability of the business. The company's common stock is listed on the NASDAQ stock exchange under the ticker symbol ISRG, and it is classified as a Health Care Equipment company within the GICS sub-industry. With a rich history dating back to its incorporation in 1995, Intuitive Surgical is headquartered in Sunnyvale, California, and can be found online at https://www.intuitive.com, with an ISIN of US46120E6023.
Additional Sources for ISRG Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ISRG Stock Overview
Market Cap in USD | 193,045m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2000-06-13 |
ISRG Stock Ratings
Growth 5y | 82.2% |
Fundamental | 43.0% |
Dividend | - |
Rel. Strength Industry | 1572 |
Analysts | 4.13/5 |
Fair Price Momentum | 589.63 USD |
Fair Price DCF | 21.64 USD |
ISRG Dividends
No Dividends PaidISRG Growth Ratios
Growth Correlation 3m | 80.4% |
Growth Correlation 12m | 95.3% |
Growth Correlation 5y | 72.4% |
CAGR 5y | 22.04% |
CAGR/Mean DD 5y | 1.62 |
Sharpe Ratio 12m | 1.70 |
Alpha | 24.13 |
Beta | 1.34 |
Volatility | 24.94% |
Current Volume | 1013.2k |
Average Volume 20d | 1308.3k |
As of December 30, 2024, the stock is trading at USD 534.88 with a total of 1,013,217 shares traded.
Over the past week, the price has changed by +1.45%, over one month by -1.31%, over three months by +8.88% and over the past year by +58.55%.
Partly, yes. Based on ValueRay Fundamental Analyses, Intuitive Surgical (NASDAQ:ISRG) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.97 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ISRG as of December 2024 is 589.63. This means that ISRG is currently undervalued and has a potential upside of +10.24% (Margin of Safety).
Intuitive Surgical has received a consensus analysts rating of 4.13. Therefor, it is recommend to buy ISRG.
- Strong Buy: 14
- Buy: 9
- Hold: 7
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, ISRG Intuitive Surgical will be worth about 662.7 in December 2025. The stock is currently trading at 534.88. This means that the stock has a potential upside of +23.9%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 550.7 | 3% |
Analysts Target Price | 332.8 | -37.8% |
ValueRay Target Price | 662.7 | 23.9% |